免疫媒介性死性肌肉病变:对病变发生,临床特征和治疗方法的全面审查
Changpei Li1, Hongjiang Liu1, Leiyi Yang1
1Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Journal of autoimmunity
|July 21, 2024
概括
免疫媒介性死肌病 (IMNM) 是一种罕见的自身免疫性疾病. 研究突出了它的免疫和非免疫机制,遗传因素和新兴治疗方法,提供了新的治疗见解.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- 免疫媒介性瘤性肌肉病 (IMNM) 是一种罕见的自身免疫性疾病.
- 它的特征是特定的自身抗体,高水平的肌酸激酶和炎症.
- 它被分为抗SRP,抗HMGCR和血清阴性亚型.
研究的目的:
- 审查了解IMNM病原体的最新进展.
- 探索IMNM的遗传关联和治疗策略.
- 为未来的IMNM研究提供见解.
主要方法:
- 关于IMNM的最新科学文献的审查.
- 免疫系统激活通路的分析.
- 检查遗传变异和治疗方式.
主要成果:
- IMNM的发病包括免疫反应 (抗体,补充物,巨细胞) 和非免疫因素 (自,ER压力).
- 遗传变异有助于IMNM的发展.
- 免疫抑制剂和生物药物在IMNM治疗中表现有前途.
结论:
- 最近的发现加深了对IMNM复杂机制的理解.
- 基因洞察力和治疗进步为改善患者结果提供了希望.
- 进一步的研究对于开发有针对性的IMNM疗法至关重要.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myocarditis I: Introduction
647
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Myocarditis II: Clinical Features and Diagnostic Tests
497
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
497
Myocarditis III: Medical Management
346
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
346
Cellular Injury IV: Necrosis
97
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
97
Myasthenia Gravis ll: Pathophysiology
75
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
75


